Matinas BioPharma Holdings, Inc.·4

Mar 18, 10:50 AM ET

Jabbour Jerome D 4

4 · Matinas BioPharma Holdings, Inc. · Filed Mar 18, 2020

Insider Transaction Report

Form 4
Period: 2020-03-17
Jabbour Jerome D
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2020-03-17$0.65/sh+10,000$6,500799,511 total
Footnotes (1)
  • [F1]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.64 to $0.65, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Documents

1 file
  • 4
    ownership.xmlPrimary